We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$439M
AUM Growth
+$17.1M
(+4.1%)
Cap. Flow
-$9.91M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
22.77%
Holding
145
New
7
Increased
57
Reduced
60
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamb Weston
LW
|
+$7.97M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.99M |
| 3 |
Hackett Group
HCKT
|
+$1.19M |
| 4 |
C.H. Robinson
CHRW
|
+$792K |
| 5 |
Camtek
CAMT
|
+$617K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$8.49M |
| 2 |
PPG Industries
PPG
|
+$8.03M |
| 3 |
Oceaneering
OII
|
+$4.51M |
| 4 |
CLCT
Collectors Universe
CLCT
|
+$967K |
| 5 |
ECHO
Echo Global Logistics, Inc.
ECHO
|
+$577K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.29% |
| 2 | Technology | 16% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Healthcare | 14.34% |
| 5 | Financials | 11.57% |
Similar funds
CM
CFFNO
RIM
TBA
JSC
MGWM
MSIIA
NFG
Isthmus Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Isthmus Partners held 145 positions worth $439M, up 4.1% from $422M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Isthmus Partners's Q4 2019 filing shows 7 new, 57 increased, 60 reduced and 6 closed positions. Its largest new stake was Lamb Weston: 98,924 shares worth $8.51M. The largest sale was Celgene Corp, an estimated $8.49M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
- Isthmus Partners's largest Q4 2019 buy was Lamb Weston: 98,924 shares worth $8.51M.
- Isthmus Partners added most to C.H. Robinson in Q4 2019, an estimated $792K increase.
- Isthmus Partners's biggest Q4 2019 reduction was Oceaneering, cutting an estimated $4.51M.
- Isthmus Partners fully exited Celgene Corp in Q4 2019, selling an estimated $8.49M.
- Isthmus Partners's ten largest holdings make up 23% of its $439M portfolio in Q4 2019.
- Isthmus Partners opened 7 new positions and closed 6 in Q4 2019.
- Isthmus Partners's portfolio value rose 4.1% quarter-over-quarter to $439M.
Based on Isthmus Partners's 13F filing for Q4 2019, filed 7 Feb 2020.